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Background: Overweight and obesity are growing public health problems in high income countries and is now
growing at a dramatic pace in low and middle income countries, particularly in urban settings. The aim of this trial
was to examine the effects of a weight reduction program in adults and to determine whether or not a more
extensive intervention was superior to ordinary care.
Methods: Patients seeking advice for overweight/obesity or illness related to overweight/obesity at eight primary
health care centers in Sweden were randomized either to intervention or control care groups with both groups
given dietary advice and individualized information on increased regular physical activity. In the intervention group
advice was more extensive and follow-up more frequent than in the control group during the study period of two
years. Main outcome measure was reduction in body weight of five percent or more from study start.
Results: From October 2004 to April 2006, 133 patients, 67 in the intervention group and 66 in the control group,
were randomized over a period of 18 months. Target weight was achieved at 12 months by 26.7% of the patients
in the intervention group compared with 18.4% in the control group (p = 0.335). There was an average absolute
weight loss of 2.5 kg in the intervention group and 0.8 kg in the control group at 12 months as compared with the
weight at study entry. There were no significant differences between the groups in quality of life, blood glucose
and lipids. At 24 months target weight was achieved in 21.9% versus 15.6%, with an average weight reduction of
1.9 kg and 1.2 kg in the two groups, respectively.
Conclusions: Promotion of a diet with limited energy intake, appropriate composition of food and increased
physical activity had limited effects on body weight in a Swedish primary care setting. More extensive advice and
more frequent visits made no significant difference to the outcome.
Trial registration: ClinicalTrial.gov: NCT01606917
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Overweight and obesity are growing public health prob-
lems in high income countries and is now growing at a
dramatic pace in low and middle income countries, par-
ticularly in urban settings [1]. Overweight and obesity are
major risk factors for a number of chronic diseases, in-
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reproduction in any medium, provided the orloskeletal disorders and cancer [2]. These diseases also
often have strongly negative effects on quality of life. In
Sweden, two million people are overweight and 500,000
are obese (both adults and children) [3,4]. The causes of
obesity are only partly known, but genetic factors play a
key role [3-5]. Although inheritance plays an important
part, obesity is a complex disorder influenced by other fac-
tors including diet, exercise, social, behavioral, cultural,
and community factors [6,7]. The economic burden of
obesity is escalating. For instance, current costs in United
States (2010) are estimated to be between $147-$210 bil-
lion for obesity-related diseases [8].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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weight and obesity have shown modest but not sustained
weight reduction over a short period, and the types
of weight-loss interventions that contribute most to
successful long-term outcomes have not yet been
established [9]. Many individuals with overweight /obes-
ity have their health related problems treated by primary
care providers. This could also be an opportunity for
providers to give patients structured advice about or in-
terventions to combat their overweight/obesity. For se-
verely obese individuals surgical treatment has been the
most successful treatment in achieving sustained weight
reduction [10]. Regardless of the method used, interven-
tions related to other risk factors can reduce CVD risk,
even when weight reduction does not succeed [11]. Re-
cently, a Swedish study in a primary health care setting
using lifestyle modifications also showed reduced cardio-
vascular risk factor levels but not weight loss [12]. An-
other obesity-related risk factor is type 2 diabetes and
for this condition physical activity with even small and
moderate weight reductions have been shown to dec-
rease the risk of developing type 2 diabetes [13].
The aim of this two years study was to examine the
short and long-term effects of a weight intervention pro-
gram in adults, seen in a primary care setting. A pre-
requisite for inclusion was that the patients consulted or
were in care for overweight/obesity. The aim was also to
compare more extensive advices with appointments and
telephone contacts with ordinary care, all done with a
pragmatic study design and with limited resources.
Methods
Patients
Adult patients between 18 and 70 years of age who
consulted or were in care for overweight/obesity with or
without type 2 diabetes, hypertension, CVD, coronary
heart disease (CHD), dyslipidemia, gallstone, or muscu-
loskeletal disorders at eight Primary Health Care Centers
(PHCC) in Örebro County, Sweden were eligible for the
trial.
Patients were not eligible if they were already taking
part in another weight control program, understood the
Swedish language poorly, were mentally ill, or had an al-
cohol or drug abuse problem. Neither were they eligible
if they had a physical disability preventing intensified
physical activity or were pregnant at study start.
In the waiting room of the PHCCs, information about
the study was posted, inviting patients to take part in
the trial. At their appointments with the GPs at the cen-
ters, patients were invited to participate in the trial if
appropriate, irrespective of whether or not the patients
asked about the study. After obtaining informed consent,
an individualized target weight was formulated. It was
also decided over what time period it should be achieved,the same for both groups. Patients were advised that a
realistic goal was a weight reduction of at least 5% by one
year after study start.
The patients were then randomized to the intervention
or control group. Figure 1 shows the flow diagram for
the patients as regards examinations and drop-outs.
Interventions
Patients in the intervention group had regular appoint-
ments five times over the first two years with both a
study nurse and a study physiotherapist. In addition, the
study nurse and the physiotherapist contacted the pa-
tient by telephone four times during study months 6, 9,
15 and 21 (Figure 1). This contact was to encourage
patients to comply with the advice given and answer
patient questions. At the appointments with the nurse,
written and illustrated information of the “plate model”
was distributed to the patients and the content described
in detail. Moreover, questions were answered and food
advice repeated. They were also given a diary in which
their physical activity was to be recorded and handed
over to the physiotherapist at the check-ups. At the ap-
pointments with the physiotherapist a personalized pro-
gram of regular exercise was designed and continuously
adjusted for each participant. At these appointments the
study nurse checked blood pressure, height, weight,
waist circumference, calculated BMI, and performed
blood tests for estimation of glucose and lipid levels.
The basis of energy restriction given was the “plate-
model”, well known in Sweden, which illustrates the
relative proportions of different food groups, in relation
to which food of adequate composition and amount was
demonstrated to the patient [14]. The model emphasizes
that the two main daily meals (lunch and dinner) should
contain no more than 25% meat, fish, chicken, eggs,
beans, or other vegetarian protein alternatives. The rest
of each meal should contain 25% potatoes, pasta or
bread and 50% vegetables or fruit. It was recommended
that water be the meal time drink. At breakfast, a sand-
wich and a bowl of yoghurt along with tea or coffee was
recommended. Between meals, a fruit or a small sand-
wich was allowed [15]. This gives an energy intake where
10-15% comes from protein, no more than 30% from fat
and the rest from carbohydrates. The advice emphasized
an important aspect of the “plate model”, namely to
limit the amount of food at each meal. No second help-
ings or snacks between meals were allowed.
In the control group the ordinary information used at
the PHCC by members of the ordinary staff (doctor,
nurse and physiotherapist) on the importance of a diet
of adequate composition, reducing the total energy in-
take, and regular physical activity for weight control was
given. Food advice was also based on the “plate-model”
with the same composition as in the intervention group.
Agreed to be randomised
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Figure 1 Participants flow diagram.
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to the patients with no further discussion on the con-
tent. Patients in the control group had a check-up with a
nurse after one month of compliance with the advice,
and a repetition of what had been said at the start. At
three months the nurse and the physiotherapist phoned
the patients to encourage patients to comply with the
advice given. They were also given a diary in which their
physical activity was to be recorded and shown to the
physiotherapist at the check-ups (Figure 1).The trial was executed only by staff members at the
participating PCHCs who all had a short instruction ses-
sion by a dietitian before study start to describe the
“plate model”, and the effects and importance of physical
activity according to the metabolic equivalent (MET) in-
tensities model by a physiotherapist [16]. In both groups,
quality of life were estimated at start, after 12 and
24 months using the Short Form 36 items (SF-36) and
EuroQol 5-D (EQ-5D) questionnaires. The ordinary
equipment such as scales, blood pressure gauge, etc., in
Table 1 Baseline characteristics among patients
Intervention group Control group
n Age, mean (SD) 67 45 (13) 66 49 (13)
Male/female (% male) 22/45 (32.8) 15/51 (22.7)
Initial weight, kg, mean (SD) 97.7 (13.7) 95.0 (13.4)
BMI, mean 33.8 33.6
Smoker (n) 10 10
Diabetes (n) 8 10
Hypertension (n) 23 26
Dyslipidemia (n) 22 22
Coronary heart disease (n) 1 5
Arthrosis (n) 23 27
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therapy or motivational interviewing was used in either
group.
Biannual meetings, lasting half a day, were organized
for the staff members by the steering committee. The
purpose of the meetings was to discuss problems that
had arisen during the study, but it was also an opportu-
nity for the steering committee to motivate the members
to keep up their involvement in the study.
The primary outcome was the proportion of patients
who achieved target weight at two years. Secondary
outcomes were weight loss, clinical or laboratory ma-
nifestations of their baseline illness (type 2 diabetes,
hypertension, CHD, dyslipidemia) or death of any
cause. Further secondary endpoints were quality of life
estimated using the SF-36 and EQ-5D forms. The trial
was approved by the regional ethics committee in Uppsala,
Sweden (204: M-300) and registered in the Current
Controlled Trials, NCT01606917.
Randomization
After written informed consent, randomization was car-
ried out using numbered sealed opaque envelopes strati-
fied for each PHCC, BMI >30 and type 2 diabetes. The
order of the envelopes was predetermined by the study
statistician and kept in a box of 20 numbered envelopes
of varying bloc sizes at each PHCC by the study coord-
inator at each centre. At randomization an envelope was
drawn in the predetermined numbered order.
Statistics
SPSS for Windows, version 17.0 (Chicago, IL) was used
for all statistical analyses. On the assumption that 50%
of the patients in the intervention group and 20% in the
control group would achieve their target weight at two
years with a power of 90% at a significance level of 0.05,
two-sided test, it was determined that 50 patients in
each group would have to be included. We estimated
that as many as 50% of the patients would have difficul-
ties in fully complying with the study protocol. We
therefore aimed to randomize 75 patients to each study
group. The analysis was per protocol. Mean with stan-
dard deviation (SD), median with quartile range and
proportion of individuals was used to summarize diffe-
rent variables. For comparisons between intervention
and control groups, chi-square test or Fischer’s exact test
when appropriate were assessed for categorical variables,
and unpaired and paired t-tests were used for continuous
variables with 95% confidence intervals. P-values less than
5% (two-sided) were regarded as statistically significant.
Results
From October 2004 to April 2006, 133 patients were
randomized, 67 to the intervention group and 66 to thecontrol group. The goal of 150 randomized patients
could not be reached because of declining interest at the
PHCCs in carrying on with inclusion of patients in the
trial. Inclusion was therefore stopped on April 30, 2006.
Baseline characteristics of the patients are given in
Table 1. No apparent differences were observed between
the groups, except that there were more men in the
intervention group and more patients with CHD in the
control group.
There were considerable difficulties for both the pri-
mary care organisation and the patients in complying
with the study protocol. Therefore only 45 patients in
the intervention group and 49 patients in the control
group contributed information at 12 months. At that
time, 26.7% of the patients in the intervention group had
a weight reduction of 5% or more as compared with
18.4% in the control group, Table 2. This difference was
not statistically significant (p = 0.335). The correspon-
ding results at 24 months were 21.9% and 15.6%, re-
spectively (p = 0.479). As seen in Table 3, there was an
absolute weight loss of 2.5 kg in the intervention group
at 12 months as compared with the initial weight at
study entry. The corresponding weight loss in the con-
trol group was 0.8 kg. The difference between the groups
was not statistically significant, -1.7 kg (95% CI −4 to 0.4
p = 0.108). At 24 months the number of patients contri-
buting to the analysis had further declined in the inter-
vention group to 32 patients while still 45 patients were
in the control group. At that time the weight loss in
each group was 1.9 kg and 1.2 kg, respectively, which
was not statistically significant, -0.7 kg (95% CI −3.4 to
1.9, p = 0.572).
There was significant weight loss in the intervention
group at 12 months as compared within the group (95%
CI −4.0 to −1.0, p = 0.001). At 24 months this difference
was no longer significant (95% CI −4.0 to 0.2, p = 0.07),
Table 3.
There were no effects on plasma glucose, blood lipids
or blood pressure between the study start and values at
Table 2 Proportion of patients achieving target weight






Achieved target weight at
12 months
12 (26.6) 9 (18.3) 0.335
Achieved target weight at
24 months
7 (21.9) 7 (15.6) 0.479
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assessed using both the SF-36 (data not shown) and the
EQ-5D form, Table 4. No statistically significant differ-
ence on these items was noticed over the first 12 months
of the trial. Too few measurements of quality of life were
made at 24 months to make any comparison meaningful.
Low compliance with the activity diary in both groups
made it impossible to evaluate the intensity of physical
activity.
Discussion
The main finding of this trial showed that intervention
was not superior to ordinary advice to promote weight
reduction. Although the difference between the groups
was not statistically significant in terms of the primary
outcome, patients in both groups had weight loss of bet-
ween 1.9 and 1.2 kg even after two years of follow-up.
The magnitude of weight loss of 2.5 kg at 12 months
in the intervention group seems mostly to have been
maintained over the next 12 months. The narrowly
missing significance (p = 0.07) may be attributed to the
smaller than planned sample size owing to high drop-
out rates. The weight loss of 3% is comparable to what
can be achieved using drugs such as orlistat and
sibutramin [3], the latter withdrawn from the market in
2010. The same weight loss was also attained for 29,560
adults referred to Weight Watchers by the National
Health Service (NHS) [17]. The maintenance of the ini-
tial weight reduction at two years is encouraging, espe-
cially because even small and moderate weight
reductions have been shown to decrease the risk of de-
veloping type 2 diabetes, one of the obesity-related risk
factors [18]. The decrease in weight loss in the interven-
tion group between 12 and 24 months was probably an
effect of the well-known difficulties in maintaining a life-
style change over time [19] as well as that attendance at
face-to-face counseling sessions decreases substantially
over time [20]. One interesting observation was that theTable 3 Weight loss at 12 and 24 months, comparisons betwe
Intervention group mean (95% CI)
n = 45 at 12 months




Weight change at 12 months, kg −2.5 (−4.0 to −1.0) −0
Weight change at 24 months, kg −1.9 (−4.0 to 0.2) −1control group had a trend of catching up with the inter-
vention group and seemed to find it easier to comply
with the treatment regime, since they had a higher par-
ticipation rate. It might be more feasible to have fewer
appointments at PHCCs and supportive telephone con-
tact between appointments for participants, as in the
control group, than to follow the regimen used in the
intervention group. Furthermore, many individuals to-
days find an intervention such as this study difficult to
fit in with all their other activities, despite the awareness
that their health would benefit, which limits their at-
tendance rate. Other unknown factors may also have
contributed to the small differences between study
groups seen at the study end. Further key factors that
have an influence on how successful individuals are in
weight loss and maintenance of new weight, include psy-
chosocial variables concerning exercise and eating be-
haviors. This was tested in a study of overweight and
obese women who underwent a behavioral obesity treat-
ment program of 12 months, with a further 12 months
(non-intervention) of follow-up. The results showed that
lowering emotional eating and adopting a flexible dietary
restraint pattern were critical for sustained weight loss
[21]. Our study did not comprise such factors.
Scientific assessments of treatment methods for over-
weight and obesity have only shown modest but not
sustained weight reduction over a short period [9], al-
though they are highly cost-effective in primary care
models [22].
A short study from eight primary care practices in the
UK reported a weight loss of 4.0 kg in the intervention
group as compared with 1.2 kg in the ordinary care
group over 12 weeks in a weight management pro-
gramme. The conclusions drawn from that study were
that it was feasible to follow the NICE guidelines [23].
Overall, very little research has been conducted on the
management of obesity in primary care practice, as was
recently concluded in a systematic review [24], in which the
best results of weight loss intervention were achieved with
primary care providers plus pharmacotherapy or intensive
counseling plus meal replacements. More recently, another
study concluded that it is not known how effective weight
loss interventions may be in real world situations such as
clinical or community practice settings [25].
Physicians’ recommendations have a strong impact on
individual health behaviors [26] and physicians have
good opportunities to help their patients further whenen and within groups
ntrol group mean (95% CI)
49 at 12 months
45 at 24 months
Mean weight difference between
groups at 12 and 24 months
(95% CI)
p
.8 (−2.3 to 0.8) −1.7 (−3.8 to 0.4) 0.108
.2 (−2.9 to 0.6) −0.7 (−3.4 to 1.9) 0.572
Table 4 EQ5-D. Proportion of patients with fewer symptoms








Motility (%) 42 (7) 35 (9) 0.571
Hygiene (%) 41 (2) 36 (3) >0.999
Main activities (%) 43 (14) 35 (9) 0.504
Pain/inconvenience (%) 39 (13) 34 (24) 0.358
Anxiety/depression (%) 41 (15) 36 (17) 0.999
Health barometer (%) 42 (48) 36 (61) 0.262
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lems. However, a recent survey among primary care phy-
sicians concluded that less than 10% reported always
referring their patients with weight related diseases for
further management [27]. Further research is needed to
identify barriers to providing care and to improving phy-
sicians’ engagement in managing healthy lifestyles in
adults. It might be better to involve other providers than
primary care based services to overcome these barriers.
For instance in one study, comparing eight different
weight loss programmes of 12 weeks duration, it was
concluded that commercially provided weight manage-
ment services were more effective and cheaper than pri-
mary care based services [28].
The Swedish Björknäs Study [12] performed at one pri-
mary health care centre managed to keep their patients in
the trial over a three-year period, with a withdrawal rate
of approximately 10-15%. The aim of the lifestyle inter-
vention was to lower cardiovascular risk factor levels.
They found statistically significant improvements in most
of their estimated parameters except for blood lipids and
plasma glucose. Our aim was a weight loss of at least 5%
compared with the weight at study start. While a weight
reduction was achieved in our trial this was not the case
in the Björknäs study. However, they found a reduction in
waist circumference and waist-hip ratio.
From the perspective of most patients with overweight
or obesity, a weight reduction of 2.5 kg is disappointing.
Bearing in mind that it takes time to become overweight
or obese it is not surprising that weight reduction also
takes time. This is a considerable challenge to any clin-
ician who sees such patients, especially when bariatric
surgery is so successful in reducing weight, both in a
short and a long-term perspective [10]. Access to bariat-
ric surgery is limited and most obese patients have to
wait to have the operation performed. During that
period, lifestyle changes like those in this trial have no
obvious drawbacks, but do have the potential to make
obese patients more fit for the surgery. In this study, just
under one fifth of the patients achieved weight loss of at
least 5% of their baseline weight. Two other studiesrecently reported that more than one third of the pa-
tients responded to lifestyle counseling with weight loss
of 5% [29,30]. Since many obese patients do not achieve
sufficient weight loss to have a meaningful impact on
their health with lifestyle changes alone, other options
must be offered, for instance, bariatric surgery.
The small effects on weight did not impact on any
aspects of quality of life as estimated using SF-36 and
EQ-5D. This is not surprising, bearing in mind the size
of the effect, the difficulties in executing the protocol
over time, and that only measurement at 12 months
could be analyzed.
Strengths and limitations
The strength of our study was that it was an attempt to
perform a study in a routine clinical setting with no
extra resources. The limitations include the difficulty of
carrying out a trial in such a setting in an organization
with a staff with high turnover and with shortages of
GPs and other professionals. This influences the con-
tinuity and the involvement of the staff members. The
regular meetings for the staff members held twice a year
could not counteract this negative progress. The impor-
tance of this is illustrated in the Björknäs study, in which
one committed person managed to keep almost all the
patients in the study throughout the whole study period
[12]. Furthermore, the staff members and participants
were not blinded to the intervention. Perhaps, if the
nurses had been blinded to the outcome (weight), their
motivation might have been better to encourage the study
participants to make the necessary lifestyle changes. This
could have led to bias.
The high drop-out rate in our trial is a major draw-
back to the internal validity of the trial results at two
years. However, the results of this trial probably reflect
what is achievable in a Swedish primary care setting
without extra added resources. The drop-out rate in this
study, 56 participants (42%), is higher than in two other
two-year studies, 5%, and 14%, respectively [29,30]. On
the other hand, follow-up data at one year from another
study showed a 30% drop-out rate [28]. The relatively
high drop-out rate in this study could introduce a selec-
tive bias, i.e. patients in the intervention group who failed
to lose weight, could have had less motivation to carry
on in the study. Moreover, reduced sample sizes at study
end result in a loss of power.
Conclusions
A multimodal intervention to promote a diet with lim-
ited energy intake and increased physical activity had
limited effects on body weight among patients in a
Swedish primary care setting. More extensive advice
and more frequent visits made no significant difference
to the outcome.
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